Immunology Expertise Svar Life Science specializes in immunology, complement system activation, and immunogenicity, presenting opportunity to upsell custom assay development, cell engineering, and contract research services to biotech and pharma companies seeking advanced immunology solutions.

AAV andPotency Platform Recent launch of the AAV Immunogenicity Assay Platform creates a cross-sell path to gene therapy developers needing robust immunogenicity assessment throughout vector design, process development, and regulatory submissions.

Expansion in Potency Testing Expansion of GMP Potency testing for biologics enables engagement with additional pharmaceutical customers requiring lot release, stability studies, and in-process controls, widening potential contract research opportunities.

Strategic Partnerships Past and ongoing partnerships with biotechnology firms and platform providers (e.g., Gyros Protein Technologies, Akero Therapeutics) indicate a track record of collaborative projects, suggesting opportunities to co-develop assays or integrate Svar platforms into partner workflows.

Free Consultancy Advantage Free consultancy initiative lowers entry barriers for prospective clients, allowing Svar to capture early engagement, gather project needs, and convert inquiries into long-term contracts for assay development, services, and platform usage.